Matthew Stanton
Stock Analyst
(n/a)
# 4,645
Out of 4,648 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $7.15 | +11.89% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.99 | +63.32% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $24.07 | -8.60% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $41.22 | +55.26% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $7.15
Upside: +11.89%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.99
Upside: +63.32%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $24.07
Upside: -8.60%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $41.22
Upside: +55.26%